Literature DB >> 9637430

Delineation of the common critical region in Williams syndrome and clinical correlation of growth, heart defects, ethnicity, and parental origin.

Y Q Wu1, V R Sutton, E Nickerson, J R Lupski, L Potocki, J R Korenberg, F Greenberg, M Tassabehji, L G Shaffer.   

Abstract

Williams syndrome (WS) is a neurodevelopmental disorder with a variable phenotype. Molecular genetic studies have indicated that hemizygosity at the elastin locus (ELN) may account for the cardiac abnormalities seen in WS, but that mental retardation and hypercalcemia are likely caused by other genes flanking ELN. In this study, we defined the minimal critical deletion region in 63 patients using 10 microsatellite markers and 5 fluorescence in situ hybridization (FISH) probes on chromosome 7q, flanking ELN. The haplotype analyses showed the deleted cases to have deletions of consistent size, as did the FISH analyses using genomic probes for the known ends of the commonly deleted region defined by the satellite markers. In all informative cases deleted at ELN, the deletion extends from D7S489U to D7S1870. The genetic distance between these two markers is about 2 cM. Of the 51 informative patients with deletions, 29 were maternal and 22 were paternal in origin. There was no evidence for effects on stature by examining gender, ethnicity, cardiac status, or parental origin of the deletion. Heteroduplex analysis for LIMK1, a candidate gene previously implicated in the WS phenotype, did not show any mutations in our WS patients not deleted for ELN. LIMK1 deletions were found in all elastin-deletion cases who had WS. One case, who has isolated, supravalvular aortic stenosis and an elastin deletion, was not deleted for LIMK1. It remains to be determined if haploinsufficiency of LIMK1 is responsible in part for the WS phenotype or is simply deleted due to its close proximity to the elastin locus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9637430     DOI: 10.1002/(sici)1096-8628(19980616)78:1<82::aid-ajmg17>3.0.co;2-k

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  16 in total

1.  A physical map, including a BAC/PAC clone contig, of the Williams-Beuren syndrome--deletion region at 7q11.23.

Authors:  R Peoples; Y Franke; Y K Wang; L Pérez-Jurado; T Paperna; M Cisco; U Francke
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Prenatal detection of unbalanced chromosomal rearrangements by array CGH.

Authors:  L Rickman; H Fiegler; C Shaw-Smith; R Nash; V Cirigliano; G Voglino; B L Ng; C Scott; J Whittaker; M Adinolfi; N P Carter; M Bobrow
Journal:  J Med Genet       Date:  2005-09-30       Impact factor: 6.318

3.  Clinical utility gene card for: Williams-Beuren Syndrome [7q11.23].

Authors:  Udo Koehler; Brigitte Pabst; Barbara Pober; Beth Kozel
Journal:  Eur J Hum Genet       Date:  2014-02-26       Impact factor: 4.246

4.  Comparative mapping of the region of human chromosome 7 deleted in williams syndrome.

Authors:  U DeSilva; H Massa; B J Trask; E D Green
Journal:  Genome Res       Date:  1999-05       Impact factor: 9.043

Review 5.  Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Heart Development and Congenital Heart Disease.

Authors:  Michelle J Doyle; Jamie L Lohr; Christopher S Chapman; Naoko Koyano-Nakagawa; Mary G Garry; Daniel J Garry
Journal:  Stem Cell Rev Rep       Date:  2015-10       Impact factor: 5.739

6.  Refinement of the genomic structure of STX1A and mutation analysis in nondeletion Williams syndrome patients.

Authors:  Yuan-Qing Wu; Bassem A Bejjani; Lap-Chee Tsui; Ariane Mandel; Lucy R Osborne; Lisa G Shaffer
Journal:  Am J Med Genet       Date:  2002-04-22

7.  DNA double-strand break signaling and human disorders.

Authors:  Toshiyuki Bohgaki; Miyuki Bohgaki; Razqallah Hakem
Journal:  Genome Integr       Date:  2010-11-05

Review 8.  CNV and nervous system diseases--what's new?

Authors:  W Gu; J R Lupski
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

9.  microRNAs and genetic diseases.

Authors:  Nicola Meola; Vincenzo Alessandro Gennarino; Sandro Banfi
Journal:  Pathogenetics       Date:  2009-11-04

10.  Cellular and clinical impact of haploinsufficiency for genes involved in ATR signaling.

Authors:  Mark O'Driscoll; William B Dobyns; Johanna M van Hagen; Penny A Jeggo
Journal:  Am J Hum Genet       Date:  2007-05-17       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.